2,3-trimethylene-4-quinazolone has been researched along with clioquinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeripothula, M; Nerella, A | 1 |
| Ayyadevara, S; Balasubramaniam, M; Bowroju, SK; Crooks, PA; Lakkaniga, NR; Penthala, NR; Shmookler Reis, RJ | 1 |
2 other study(ies) available for 2,3-trimethylene-4-quinazolone and clioquinol
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Design; Electrophorus; Horses; Indoles; Kinetics; Mice; Molecular Docking Simulation; Neuroprotective Agents; Peptide Fragments; Protein Binding; Protein Multimerization; Quinazolines; Rats | 2021 |
Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzylamines; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Horses; Humans; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Structure-Activity Relationship | 2021 |